Ignite Creation Date:
2025-12-24 @ 1:50 PM
Ignite Modification Date:
2026-01-01 @ 9:44 PM
Study NCT ID:
NCT03390595
Status:
COMPLETED
Last Update Posted:
2023-10-18
First Post:
2017-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma
Sponsor:
Associació per a la Recerca Oncologica, Spain
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MS100070_0160
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None